Immune cells depicted by CD45 immunohistochemistry were observed in tumor and stroma up to day 21 indicating that 3D-OTC is suitable to monitor tumor–immune interactions over time which is of particular interest for capturing current immunotherapy approaches. The gene discussed is PTPRC; the disease is neoplasm.